These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2544287)
41. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
42. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
43. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Headache; 2005; 45(7):874-82. PubMed ID: 15985104 [TBL] [Abstract][Full Text] [Related]
44. The hospital management of severe migrainous headache. Jauslin P; Goadsby PJ; Lance JW Headache; 1991 Nov; 31(10):658-60. PubMed ID: 1663091 [TBL] [Abstract][Full Text] [Related]
45. Sumatriptan for the treatment of acute migraine headache. Long K; Long R Nurse Pract Forum; 1993 Sep; 4(3):124-5. PubMed ID: 8396482 [No Abstract] [Full Text] [Related]
46. The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Diener HC; Tfelt-Hansen P; de Beukelaar F; Ferrari MD; Olesen J; Dahlöf C; Mathew N; Cephalalgia; 2001 Jul; 21(6):672-9. PubMed ID: 11531899 [TBL] [Abstract][Full Text] [Related]
47. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH). Dahlöf C Headache; 1993 Apr; 33(4):201-2. PubMed ID: 8388371 [No Abstract] [Full Text] [Related]
48. [Physiopathology of the migraine crisis and its treatment with a 5-HT1-like agonist]. Arch Neurobiol (Madr); 1989; 52(5):254-6. PubMed ID: 2559670 [No Abstract] [Full Text] [Related]
49. [Migraine and sumatriptan]. Stovner LJ Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2384-5. PubMed ID: 8397451 [No Abstract] [Full Text] [Related]
50. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan. Spierings EL Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753 [No Abstract] [Full Text] [Related]
51. [Sumatriptan (Imigran) and migraine with aura--is the price too high?]. Olsen TS Ugeskr Laeger; 1992 Oct; 154(43):2989-90. PubMed ID: 1334291 [No Abstract] [Full Text] [Related]
52. Sumatriptan arrests migraine aura. Rose FC Headache; 1992 Jul; 32(7):366. PubMed ID: 1326500 [No Abstract] [Full Text] [Related]
53. Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache. Gawel MJ; Rothbart P; Jacobs H Headache; 1993 Feb; 33(2):96-7. PubMed ID: 8384612 [TBL] [Abstract][Full Text] [Related]
54. Cost of sumatriptan. Feczko JM Lancet; 1992 Jul; 340(8813):243. PubMed ID: 1353163 [No Abstract] [Full Text] [Related]
55. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. MacIntyre PD; Bhargava B; Hogg KJ; Gemmill JD; Hillis WS Circulation; 1993 Feb; 87(2):401-5. PubMed ID: 8381056 [TBL] [Abstract][Full Text] [Related]